By: Dr Israa Omar MBBS, MRCP, MSc pharmacology

Slides:



Advertisements
Similar presentations
Agents Used in the Treatment of Hyperlipidemia
Advertisements

Drugs in dyslipidaemias
Lipid-lowering drugs. Atherosclerosis and lipoprotein metabolism Atheromatous disease is ubiquitous and underlies the commonest causes of death (e.g.
DRUGS for DYSLIPIDEMIAS MED PHARM 2/22/2010 DYSLIPIDEMIAS A MODIFIABLE RISK FACTOR for CV DISEASE LIFESTYLE MODIFICATION WORKS BETTER THAN DRUGS AND.
Drugs and Dyslipidemias (statins and other lipid and atherosclerosis-modifying drugs) October 18, 2006 Frank F. Vincenzi.
Diagnosis and Treatment of Dyslipidemia  New guidelines are based on the “Adult Treatment Plan III (ATP III)” 2004  Focus = multiple risk factor assessment.
Treatment of Dyslipidemia SDPI CGP Healthy Heart Project March 8, 2006.
Cholesterol.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 50 Prophylaxis of Coronary Heart Disease: Drugs That Help Normalize Cholesterol.
ANTILIPEMICS LILLEY, READING & WORKBOOK: CHAP 28 Cardiovascular System.
Pharmacology of Agents Used in Hyperlipidemia
HYPERLIPIDEMIAS  Conditions in which the concentrations of cholesterol or triglyceride carrying lipoproteins exceed arbitrary normal limits.
Antiatherosclerosis drugs. Lipid-regulating drugs  Background  Lipoprotein  Classification of Lipoprotein: CM 、 VLDL 、 IDL 、 LDL 、 HDL 、 Lp(a) CM 、
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 29 Antilipemic Drugs.
Cholesterol synthesis and breakdown Dr. Carolyn K. Suzuki 1.
The Antihyperlipidemic Medications l Classifications of Lipoproteins – Chylomicrons l Formed in the mucosal cells of the gut l Protein coated dietary lipids.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 29 Hypolipidemic Drugs.
Kirk Mykytyn, Ph.D. Department of Pharmacology
Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium sized arteries.
Hyperlipidemia Hyperlipoproteinemia Hyperlipoproteinemia (cholesterol, Triglyceride, LDL-C, VLDL) Lead to atherosclerosis and Coronary artery disease.
Antidislipidemic drugs ( Summary ) © Dr Ivan Lambev, PhD Medical University of Sofia, Faculty of Medicine Department.
ANTIHYPERLIPIDEMIC DRUGS
Hperlipidemia:- Treatment and Management Presented by:- Dr. Tewari.
Antihyperlipidemia.
Arteriosclerosis= hardening of the arteries.. ↑Serum cholesterol (above 4mmol/L)  ↑risk of coronary heart disease
Antihyperlipidemic Drugs Hyperlipidemias. Hyperlipoproteinemias. Hyperlipemia. Hypercholestrolemia. Direct relationship with acute pancreatitis and atherosclerosis.
Management & Medications  Diet, weight loss and drug therapy are the mainstay of treatment, while exercise training is used as adjunctive therapy  Lipid-lowering.
Antihyperlipidemic drugs The clinically important lipoproteins are LDL low density lipoprotein, VLDL very low density lipoprotein, HDL high density lipoprotein.
Part 5 Antiatheroscleotic drugs. §Plasma lipids § Cholesterol free cholesterol (FC) § cholesterolester (CE) § Triglyceride (TG) § Phospholipid (PL)
Step 3 P-treatment: Drug Class Selection. Pharmacological and Non- Pharmacological Management Dyslipidemia drug therapyLifestyle modification Smoking.
Chapter 19 Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium.
Jiří Slíva, M.D. statins (inhibitors of HMG-CoA reductase) fibrates anion - exchange resins nicotinic acid group.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 28 Antilipemic Drugs.
HLD Tx & AHA/ACC Guidelines
Hyperlipidemia Hyperlipidemia and hyperlipoproteinemia are general terms for elevated concentrations of lipids and lipoproteins in the blood. hypercholesterolemia.
Management of Hyperlipoprotinaemia
1 HYPOLIPIDAEMICS or LIPID LOWERING DRUGS. 2 Hypolipidaemic agents, or antihyperlipidemic agents, are a diverse group of pharmaceuticals that are used.
Chapter 21 Agents Used in the Treatment of Hyperlipidemia.
Drugs Used to Treat Dyslipidemias Chapter 22 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Anti hyperlipidemic drugs (lipid lowering drugs) Department of Pharmacology Faculty of Medicine AIMST UNIVERSITY 5 September 2012.
HYPERLIPIDEMIA  Coronary heart disease (CHD) is the cause of about half of all deaths. The incidence of CHD is correlated with elevated levels of low-density.
50 Drugs that Help Normalize Cholesterol & Triglyceride Levels
Overview Lipoprotein metabolism Digestive lipid metabolism
Prophylaxis of Coronary Heart Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels.
Drugs Used in Hyperlipidemia
Antihyperlipidemic Drugs
Cholesterol metabolism
Hyperlipidemias.
أبدا لم يفت الاوان لكي تبدأ
Drugs for Lipid Disorders
Statins induced myopathy
Drugs for hyperlipidemia
Anti-Hypercholesterolemic Agents
Drugs for Hyperlipidemia
Formative Test.
Applied Therapeutics Dr. Riyadh Mustafa Al-Salih
18 Dyslipidemia Lect -2- Dr.Hozan.
Antihyperlipidemic Drugs
Anti-Hypercholesterolemic Agents
Drugs for Hyperlipidemias
Biosynthesis and Metabolism of Cholesterol
Antilipidaemic agents
Antihyperlipidemic Drugs
Cardiovascular System
Antilipemic Agents Lilley Pharmacology Text: Chapter 27
Major classes of drugs to reduce lipids
Introduction to Clinical Pharmacology Chapter 34 Antihyperlipidemic Drugs.
Drugs for Hyperlipidemia
Lipoproteins   Macromolecular complexes in the blood that transport lipids Apolipoproteins   Proteins on the surface of lipoproteins; they play critical.
ATP III Guidelines Drug Therapy FUTURE RESEARCH.
Presentation transcript:

By: Dr Israa Omar MBBS, MRCP, MSc pharmacology Lipid lowering agents By: Dr Israa Omar MBBS, MRCP, MSc pharmacology

HMG-CoA reductase inhibitors Reduces plasma concentration of LDL- Cholestrol by more than 30%. Also cause a small reduction on plasma TGA and a small increase in plasma HDL (statins)include simvastatin, pravastatin, atorvastatin. REDUCE THE RISK OF CORONARY RTERY DISEASE BY 42%

MOA Suppress HMG-COA reductase in the liver and therefore depress the production of cholesterol, which leads to increase synthesis of LDL receptors . As a result, the clearance of LDL is enhanced

Clinical uses To treat patient with hyperlipidemia

Adverse effects GIT disturbance Insomnia Rash More serious adverse effects (myositis, hepatitis, angio-oedema )

fibrates Include clofibrate, gemofibrate, fenofibrate. Mainly reduce VLDL and hence triglyceride . Also reduce LDL and increase HDL Gemofibrozil has been shown to reduce coronary heart disease by one third compared to the placebo in male patients with primary hyperlipidaemia

MOA Stimulate the lipoprotien lipase in the peripheral tissues, and hence, increase hydrolysis of TGA in chylomicron and VLDL particles. Also probably reduce hepatic VLDL production and increase LDL uptake

Clinical uses To treat patients with mixed hyperlipidemia (raised TGA and raised cholestrol)

Adverse effects Myositis which can cause myoglobinuria and acute renal failure Clofibrate can cause gallstone so its use is limited to patients who have had cholcystomy

Bile acid-binding resins Cholestyramine and Colestipol They reduce the plasma concentration of LDL-cholestrol by more than 10%

MOA They sequester the bile in the intestine and prevent their reabsorption and entero- hepatic recirculation. This lead to increase expression of LDL receptors in the liver and hence removal of LDL from the blood

Clinical uses Used in addition to statins to treat hyperlipidemia

Adverse effect N/V, abdominal pain , bloating, constipation or diarrhea are the commonest adverse effects They interfere with absorption of fat- soluble vitamins and drugs like Digoxin and Warfarin

Nicotinic acid derivatives Mechanism of action is poorly understood It is a water soluble vitamin Inhibit the production of hepatic triglyceride and VLDL secretion with reduction of in TGA and LDL and increase HDL It increase the blood sugar and causes flushing of the face an effect that can be reduced by taking Aspirin Modified release prepartion are well tolerated

Ezetimibe Specifically inhibits absorption of cholesterol by blocking NPC1L1 in the brush border without affecting the absorption of bile salts or fat soluble vitamins Combined with statins to treat patients with severe dyslipidemia Generally well tolerated but can cause diarrhea, headache, rash and angioedema also reported

Thank you

Reference RANGE AND DALE ,PHARMACOLOGY